The 3M™ Tegaderm™ CHG Dressing integrates the powerful antimicrobial activity of Chlorhexidine Gluconate (CHG) with the high performance of a Tegaderm dressing. In vitro testing has demonstrated that the Tegaderm Chlorhexidine Gluconate (CHG) gel pad has a broad antimicrobial effect against a variety of gram-positive and gram-negative bacteria, and yeast, including organisms most commonly associated with catheter-related bloodstream infections.
Innovative Transparent Gel Pad
Chlorhexidine (CHG) has been dissolved into a soft gel pad to provide a reservoir for consistent and continuous antimicrobial action over time
The gel pad is active on contact without requiring additional moisture
CHG migrates under the catheter to provide continuous circumferential antimicrobial protection at the insertion site
Soft and conformable, the gel pad moulds around the catheter and hub
Trusted Tegaderm Film
Original frame delivery system to ensure accurate positioning and less waste
Reinforced soft cloth section and two sterile securing strips for maximum catheter secural
The entry site is protected by the trusted Tegaderm film which acts as a barrier to water, virus and bacteria, reducing the risk of infection
Benefits
Efficacy
Proven on skin flora of healthy volunteers to reduce skin flora under the dressing and prevent re-growth for 10 days
Transparent
The CHG gel pad and the Tegaderm dressing are transparent and allow permanent visual inspection of the I.V. site without having to change the dressing
Absorbent
The Chlorhexidine Gluconate (CHG) gel pad can absorb up to 8 times its weight in saline and 3 times its weight in blood, without loss of antimicrobial activity or loss of visibility of the insertion site
Easy to apply
Frame design for ease of delivery and 2-handled application style to encourage aseptic application
Application and Removal
Information on the correct method of application and removal of the 3M™ Tegaderm™ CHG Dressing can be found in our application and removal guide.
CHG is an active antimicrobial component of the Tegaderm CHG dressing gel pad. The gel is composed of water, 2% chlorhexidine gluconate and other polymers. Since the CHG is dissolved in the gel pad it is immediately available to provide antimicrobial action upon application to skin.
In accordance with current EPIC guidelines, transparent adhesive dressings for Central Venous Catheters/PICCs should be changed when the integrity of the dressing is compromised or at seven days. The dressing should be changed if any drainage is not contained in the gel, leaks beyond the gel pad, or obscures visualisation of the site.
Tegaderm CHG dressing has been shown to effectively inhibit re-growth of skin flora on healthy subjects for up to 10 days. However, consistent with current Guidelines and RCN Standards, dressing may be safely left in place for up to seven days.
Yes. According to all guidelines, the skin requires disinfection with an appropriate antiseptic before catheter insertion and during dressing changes. A 2% chlorhexidine-based preparation is preferred in most UK guidelines. Tegaderm CHG dressing is designed to work with any prepping agent. Use of Tegaderm CHG dressing has been demonstrated to reduce skin flora counts on healthy subjects to lower levels than can be achieved with skin preps alone. In addition, antimicrobial protection will be provided continuously at the site for up to ten days, whereas no prep claims to have significant activity past 48 hours.
Yes. Cavilon No Sting Barrier Film is compatible with Tegaderm CHG dressing. Cavilon No Sting Barrier Film swabs may be used to prevent skin trauma on removal of a dressing. It should be carefully applied to the skin, BUT avoiding the area immediately surrounding the insertion site and where the CHG gel pad is placed. Cavilon™ No Sting Barrier Film foam applicators are recommended for I.V. sites.
Slowly peel the dressing from the skin, towards the insertion site using a “low and slow” removal method. To facilitate removal of the gel pad from the catheter and manufactured catheter stabilisation device, use of a sterile fluid (e.g. saline, alcohol wipe) is recommended. (Note: alcohol should not be used for epidural catheters.) As the gel pad adhesion is released, continue the “low and slow” removal method.
The safety and effectiveness of Tegaderm CHG dressings has not been evaluated in children under 18 years of age. Do not use Tegaderm CHG dressings on premature infants. Current literature about the use of CHG on premature infants suggests that use of Tegaderm CHG on infants with under-developed skin could result in hypersensitivity or necrosis of the skin.
Tegaderm CHG dressing is effective where the CHG gel pad is in contact with skin and its surrounding inhibition zone. There may be problems achieving effective contact of the gel pad with the puncture site. Providing this is achieved, Tegaderm CHG may be used with implanted ports.
Tegaderm CHG dressing can be used with any device that would benefit from skin flora reduction. Devices at risk for microbial contamination that could benefit from Tegaderm CHG dressing include, but are not limited to: any intravenous, intra-arterial, epidural, and hyperdemoclysis therapies, and all dialysis catheters. NB: Tegaderm CHG is designed for skin applications and not mucosal use.
Tegaderm CHG dressing is effective where the CHG gel pad is in contact with the skin and its surrounding inhibition zone. When applied to sutured catheters and sutured devices additional antimicrobial barrier protection is provided to the suture site as well as the insertion site.
Documentation
To view in a browser window click the 'View' button. Alternatively right-click and select 'Save Target As...' to save a document to your local machine or network.
Title
Format
Size
View
Tegaderm CHG Detailed Guide
277KB
Tegaderm CHG Application Guide
194KB
Clinical Evidence
To view in a browser window click the 'View' button. Alternatively right-click and select 'Save Target As...' to save a document to your local machine or network.
Title
Format
Size
View
A Novel Integrated Chlorhexidine-impregnated Transparent Dressing for Prevention of Vascular Catheter-related Bloodstream Infection: A Prospective Comparative Study in Healthy Volunteers Dr. Dennis Maki‚ University of Wisconsin School of Medicine and Public Health
172KB
Prospective‚ Randomized‚ Controlled Trial Accessing the Clinical Performance of a Transparent Chlorhexidine Gel Pad Intravascular Catheter Dressing Dr. Mark Rupp‚ University of Nebraska Medical Center
70KB
Accomplishing Zero Bloodstream Infections with Chlorhexidine Gluconate Transparent IV Securement dressing Patricia Gould, RN & Antje Oudakker, RN, St. Joseph's Mercy Health Center, Hot Springs, AR.
220KB
Antimicrobial Activity of a CHG-Impregnated Gel Pad for IV Site Protection Debra Schwab‚ 3M Senior Research Microbiologist and Linda Olson‚ Research Microbiologist
211KB
A Multicenter prospective open label evaluation of the clinical performance of a chlorhexidine gluconate antimicrobial transparent dressing Mary Deschneau‚ 3M Senior Technical Service Specialist
2.27MB
Antimicrobial Activity for IV Site Evaluation‚ Autumn Anderson‚ Nurse Manager‚ Inpatient Infusion Team‚ Antimicrobial Activity for IV Site Evaluation Park Nicollet Methodist Hospital‚ Minneapolis‚ Minnesota.
288KB
Clinical Performance of a New Transparent Chlorhexidine Gluconate Central Venous Catheter Dressing (Ease of Use Study) Carol Olson‚ RN-BC and the Vascular Access Team of Abbott Northwestern Hospital
269KB
Migration of Chlorhexidine Gluconate Under Antimicrobial Gel Pad of IV Securement Dressing to Provide Continuous Antimicrobial Protection Debra Schwab‚ 3M Senior Research Microbiologist‚ and team
162KB
A Controlled Randomized Prospective Comparative Pilot Study to Evaluate the Ease of Use of a Transparent CHG Gel Dressing vs. a CHG Disk in Healthy Volunteers Chou Eyberg‚ 3M Clinical Research
726MB
Suppression of Regrowth of Normal Skin Flora under Chlorhexidine Gluconate Dressings Applied to CHG-Prepped Skin M.H. Bashir
138KB
The Absorptive Abilities of a CHG Gel Dressing: Can Initial Gauze Dressings be Avoided Carol Olson‚ RN-BC and the Vascular Access Team of Abbott Northwestern Hospital
978KB
Growth Inhibition of Microorganisms Involved in Catheter-Related Infections by an Antimicrobial Transparent IV Dressing Containing Chlorhexidine Gluconate (CHG) J.P. Hensler', D. L. Schwab", L.K. Olson'(1), M. Palka-Santini(2), (1) 3M Health Care, St. Paul, MN, US; (2) 3M Deutschland GmbH, Neuss, GE
385KB
Economic Evaluation of Antimicrobial IV Dressings Jonathan Brenner, MBA‚ (3M Heath Care)
574KB
Evaluation of a New CHG Gel Pad Dressing for Catheter Care Cindy Zehrer, RN, MS, Graham Smith, BS, Mary Deschneau, RN, BSN
